Theravance (Nasdaq:THRX) is a biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.
Recent Mentions on Fool.com
- A Sad Reality: 3 of Healthcare's Top 5 Dividends Probably Aren't Sustainable
- 3 Value Stocks Near 52-Week Lows Worth Buying
- Monday?s Top Biotech Stories: Spectrum, Bristol-Myers Squibb, GSK, and Theravance
- This COPD Investment Opportunity Isn't What It Seems
- This Diversified Health Care Portfolio Could Yield You 4.2% Annually!